Saudi Arabia In-Vitro Fertilization (IVF) Market By Technique (ICS/IVF, Non-ICSI/Traditional IVF), By Reagent (Embryo Culture Media, Cryopreservation Media, Sperm Processing Media, Ovum Processing Media), By Instrument (Imaging Systems, Incubators, Cryo-systems, Sperm Separation Systems, Ovum Aspiration Pumps, Micromanipulator Systems, Others), By Infertility (Female, Male), By Embryo (Frozen-Thawed Embryo, Fresh Embryo), By Application (Fertility Clinics, Hospitals, Others), By End-User (Locals, Expats, Medical Tourists), By Region and Competition, Forecast & Opportunities, 2021-2031F

Key Insights	Details
Forecast Period	2027-2031
Market Size (2025)	USD 234.66 Million
CAGR (2026-2031)	9.71%
Fastest Growing Segment	Frozen-Thawed Embryo
Largest Market	Northern & Central
Market Size (2031)	USD 409.18 Million

Market Overview

The Saudi Arabia In-Vitro Fertilization (IVF) Market will grow from USD 234.66 Million in 2025 to USD 409.18 Million by 2031 at a 9.71% CAGR. In-Vitro Fertilization (IVF) is a medical procedure involving the fertilization of an egg by sperm outside the body, in a laboratory setting, to assist individuals or couples experiencing infertility to conceive. The Saudi Arabia IVF market is driven by several factors, including the high prevalence of infertility, increasing awareness and acceptance of advanced reproductive technologies, and a growing trend of delayed parenthood. Additionally, supportive government initiatives enhancing healthcare infrastructure and promoting medical tourism contribute to market expansion. According to observations related to the Saudi Society for Reproductive Medicine, the annual number of IVF cycles performed in Saudi Arabia has recently surpassed 20,000.

Ongoing technological advancements, such as Intracytoplasmic Sperm Injection (ICSI) and preimplantation genetic testing, further bolster market growth by improving success rates. However, a significant challenge impeding market expansion is the high cost of IVF treatments coupled with limited insurance coverage. Many private insurance policies do not comprehensively cover infertility treatments, creating a financial barrier for numerous couples seeking assistance.

Key Market Drivers

Rising Infertility and Demographic Growth Drive IVF Demand
Rising infertility prevalence significantly drives the Saudi Arabia In-Vitro Fertilization (IVF) market. Factors such as evolving lifestyle choices, the increasing trend of delayed parenthood, and various medical conditions contribute to a growing number of individuals and couples experiencing fertility challenges. This demographic shift naturally expands the potential patient base for assisted reproductive technologies. According to the United Nations Population Division, updated in November 2025, the female population of reproductive age in Saudi Arabia is projected to reach 8.25 million persons in 2026, indicating an increasing cohort who may eventually seek fertility assistance.

Advances in Reproductive Technologies and AI-Driven IVF Expand Market Activity
Concurrently, continuous advancements in reproductive technologies play a crucial role in expanding the market by improving treatment efficacy and offering solutions for a wider range of infertility issues. Innovations such as enhanced genetic screening and improved laboratory techniques lead to higher success rates, thereby increasing patient confidence and demand for IVF procedures. A notable advancement occurred when Bnoon Network of Fertility & Women's Health Centers announced, in April 2026, the first birth in Saudi Arabia following the use of an AI-enabled sperm selection application during IVF treatment. This technological integration enhances precision in embryo selection and development. Furthermore, illustrating the market's ongoing activity, Bnoon performs over 5,000 IVF cycles annually.

Download Free Sample Report

Key Market Challenges

Cost and coverage constraints impede market growth
The high cost of In-Vitro Fertilization (IVF) treatments, combined with limited insurance coverage, represents a significant impediment to the growth of the Saudi Arabia IVF Market. IVF procedures are inherently resource-intensive, involving specialized equipment, highly skilled medical professionals, and costly medications across multiple treatment cycles. This necessitates substantial out-of-pocket expenses for many individuals and couples, as private insurance policies in Saudi Arabia frequently do not offer comprehensive coverage for infertility treatments.

Financial barriers and income disparities limit access and uptake
The financial burden consequently creates a barrier to access, preventing a considerable portion of the population from pursuing or completing necessary fertility treatments. Economic disparities mean that lower and intermediate-income families may find it particularly challenging to afford the full cost of multiple IVF cycles, which are often required for a successful pregnancy. This directly restricts the patient pool and limits the overall uptake of advanced reproductive technologies, thereby hampering the potential expansion of the market beyond current participation levels.

Key Market Trends

Expansion of IVF clinic networks and new facilities
The Saudi Arabia In-Vitro Fertilization (IVF) market is experiencing significant expansion through the development of advanced fertility clinic networks, enhancing patient access and service availability across key regions. Leading providers are actively broadening their physical footprint and integrating new facilities to cater to increasing demand. For instance, Bnoon Network of Fertility & Women's Health Centers acquired HealthPlus Fertility Center in Jeddah in June 2025, further extending its operational reach. This expansion is complemented by the development of new, specialized facilities, such as the 3,800 square meter flagship center on King Salman Road in North Riyadh, which is scheduled to open in early 2026.

Private-sector investment and acquisitions propel market growth
Concurrently, rising private sector investment in fertility services is a prominent trend, fueling market growth through strategic acquisitions and capital injections. This financial backing enables providers to enhance infrastructure and adopt advanced technologies. For example, Global Fertility Network (GFN), which operates the Bnoon brand, completed two strategic acquisitions in Saudi Arabia, including HealthPlus Fertility Center in Jeddah, representing an investment exceeding 100 million Saudi Riyals (approximately USD 27 million) in June 2025. This demonstrates a clear commitment from private entities to capitalize on the growing demand for assisted reproductive technologies within the Kingdom.

Segmental Insights

Frozen-Thawed Embryo as a Key Growth Driver in Saudi Arabia's IVF Market
The Frozen-Thawed Embryo segment is a key growth driver within the Saudi Arabia In-Vitro Fertilization (IVF) market. This expansion stems from evolving social dynamics, notably a trend towards delayed parenthood due to increased focus on education and career paths, elevating the demand for fertility preservation. Concurrently, significant technological advancements in cryopreservation, including improved media formulations and nanotechnology applications, have substantially enhanced embryo viability and overall IVF success rates. These innovations, supported by the ethical framework provided by the Ministry of Health and religious permissibility from the Council of Senior Scholars for personal use, offer patients greater flexibility and improved outcomes in their fertility journeys.

Regional Insights

Northern & Central Region: Infrastructure, Access, and Regulatory Oversight Driving IVF Market Leadership
The Northern & Central region spearheads the Saudi Arabia In-Vitro Fertilization market primarily due to its developed and comprehensive healthcare infrastructure, encompassing specialized fertility clinics and highly trained medical professionals. This concentration of advanced facilities within densely populated and economically robust urban centers ensures enhanced accessibility and greater affordability of IVF services for a substantial patient base. Additionally, increased public awareness regarding fertility treatments, coupled with the Ministry of Health's active role in supervising fertility center licensing and ensuring adherence to national regulations for treatment units, significantly drives market dominance in this region.

Recent Developments

• In December 2025, Bnoon, part of the Global Fertility Network, announced the development of a 3,800 square meter flagship fertility and women's health facility in North Riyadh. This new center was scheduled to open by the end of 2025 and was designed to feature advanced IVF and embryology laboratories equipped with time-lapse incubation and AI-powered embryo selection technologies. This initiative marked a significant new product launch in the Saudi Arabia IVF Market, aiming to enhance treatment outcomes through cutting-edge artificial intelligence for improved embryo selection.
• In June 2025, Global Fertility Network (GFN) completed the acquisition of a majority controlling stake in HealthPlus Fertility Center located in Jeddah. This acquisition, along with an earlier purchase of Bnoon IVF Center in Riyadh, represented an investment exceeding 100 million Saudi Riyals (approximately USD 27 million). Both acquired facilities were subsequently rebranded under GFN's Bnoon IVF network. This strategic consolidation aimed to establish the largest fertility network in Saudi Arabia, significantly increasing the capacity for assisted reproductive services in the region.
• In September 2024, Burjeel Holdings PLC announced its strategic plans to introduce comprehensive In-Vitro Fertilization (IVF) services in Saudi Arabia. This expansion was designed to complement the company's existing gynecology, fetal medicine, and pediatric subspecialties, thereby strengthening integrated women's healthcare offerings. The initiative included the establishment of a dedicated Trust Fertility Clinic within Burjeel Medical City, focusing on advanced reproductive care and contributing to the growing IVF services available in the Kingdom.
• In July 2024, researchers at King Faisal Specialist Hospital & Research Centre published findings on the critical role of the protein Phospholipase C Zeta (PLCζ) in early embryo development and implantation within the Saudi Arabia In-Vitro Fertilization (IVF) Market. Their study indicated that defects in PLCζ gene expression could contribute to infertility and implantation failure, highlighting its importance for successful embryo implantation. This breakthrough research underscored the potential for advancements in reproductive treatments by improving understanding of the factors essential for a successful pregnancy in IVF procedures.

Key Market Players

• Fakih IVF
• New Hope IVF
• Conceive Gynecology & Fertility Centre
• Burjeel Day Surgery
• American Hospital Fertility
• NMC Fertility
• Aster IVF
• Medcare Fertility
• HealthPlus Fertility

By Technique	By Reagent	By Instrument	By Infertility	By Embryo	By Application	By End-User	By Region
ICS/IVF Non-ICSI/Traditional IVF	Embryo Culture Media Cryopreservation Media Sperm Processing Media Ovum Processing Media	Imaging Systems Incubators Cryo-systems Sperm Separation Systems Ovum Aspiration Pumps Micromanipulator Systems Others	Female Male	Frozen-Thawed Embryo Fresh Embryo	Fertility Clinics Hospitals Others	Locals Expats Medical Tourists	Eastern Northern & Central Western Southern

Report Scope:

In this report, the Saudi Arabia In-Vitro Fertilization (IVF) Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Saudi Arabia In-Vitro Fertilization (IVF) Market, By Technique:

• ICS/IVF
• Non-ICSI/Traditional IVF

• Saudi Arabia In-Vitro Fertilization (IVF) Market, By Reagent:

• Embryo Culture Media
• Cryopreservation Media
• Sperm Processing Media
• Ovum Processing Media

• Saudi Arabia In-Vitro Fertilization (IVF) Market, By Instrument:

• Imaging Systems
• Incubators
• Cryo-systems
• Sperm Separation Systems
• Ovum Aspiration Pumps
• Micromanipulator Systems
• Others

• Saudi Arabia In-Vitro Fertilization (IVF) Market, By Infertility:

• Female
• Male

• Saudi Arabia In-Vitro Fertilization (IVF) Market, By Embryo:

• Frozen-Thawed Embryo
• Fresh Embryo

• Saudi Arabia In-Vitro Fertilization (IVF) Market, By Application:

• Fertility Clinics
• Hospitals
• Others

• Saudi Arabia In-Vitro Fertilization (IVF) Market, By End-User:

• Locals
• Expats
• Medical Tourists

• Saudi Arabia In-Vitro Fertilization (IVF) Market, By Region:

• Eastern
• Northern & Central
• Western
• Southern